These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 926549)

  • 1. [Calculation of the size of the population group necessary for evaluation of the results of measures for the prevention of cardiovascular diseases (on the example of the Kaunas survey)].
    Daud DE; Glazunov IS; Ianushkevichus ZI
    Kardiologiia; 1977 Aug; 17(8):10-6. PubMed ID: 926549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevention of cardiovascular disease in the elderly].
    Belmin J
    Presse Med; 2000 Jun; 29(22):1234-9. PubMed ID: 10916537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Participation of the population in mass screening and the role of complete population surveillance for detection of the disease studied (from the experience of the methodical measures for the prevention of ischemic heart disease in Kaunas)].
    Baubinene AV; Domarkene SB; Glazunov IS; Grabauskas VI; Pampikas SI
    Kardiologiia; 1977 Aug; 17(8):16-20. PubMed ID: 926564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality and morbidity indicators of acute myocardial infarction in participants and non-participants in population studies conducted in Moscow and Kaunas.
    Tamosjunas AA; Baubiniene AV; Chazova LV; Domarkene SB; Macjavicjute NA; Pavlova LI; Reklajtene RA; Kalinina AM
    Cor Vasa; 1989; 31(4):264-71. PubMed ID: 2805699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multifactorial prophylaxis of ischemic heart disease (a cooperative study)].
    Chazova LV; Glazunov IS; Baubinene AV; Domarkene SB; Zborovskiĭ EI
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(1):43-8. PubMed ID: 6860474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Secondary prevention of arterial hypertension in an organized population: methods of implementation, efficacy, prospects].
    Merzon AK; Kolomiets VV; Reznichenko LI
    Kardiologiia; 1987 Jan; 27(1):69-74. PubMed ID: 3560632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prospective epidemiologic study of arterial hypertension in an organized male population].
    Markov KV; Smirnov IuV; Vedeneeva IA
    Kardiologiia; 1987 Jan; 27(1):74-7. PubMed ID: 3560633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experience in conducting a multifactor ischemic heart disease prevention program (data from a cooperative study in Moscow and Kaunas].
    Glazunov IS; Chazova LV; Baubinene AV; Prokhorskas R; Shishova AM
    Kardiologiia; 1980 Jul; 20(7):31-5. PubMed ID: 7401438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heart and brain: are the risk factors the same? Are the results of primary and secondary trials comparable?].
    Castaigne A; Haziza F; Lopes-Darmon ME
    Arch Mal Coeur Vaiss; 1998 Oct; 91 Spec No 5():59-63. PubMed ID: 9833081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intervention in risk factors and protection of target organs].
    Gascón Ramón G; Bertomeu i Blanch F; Baño Aracil M; Madrigal JA
    An Med Interna; 1997 Sep; 14(9):478-84. PubMed ID: 9453760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic factors in myocardial infarction--Results from a candidate gene and a genome-wide approach between beta blockers].
    Hengstenberg C; Bröckel U; Holmer S; Mayer B; Fischer M; Baessler A; Erdmann J; Lieb W; Löwel H; Riegger G; Schunkert H
    Herz; 2002 Nov; 27(7):649-61. PubMed ID: 12439636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Organization of the control of the cardiovascular diseases in the Lithuanian SSR].
    Ianushkevichus ZI
    Kardiologiia; 1980 Jul; 20(7):10-5. PubMed ID: 7401430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of cardiovascular morbidity and mortality in hypertension: benefits of blood pressure reduction and cholesterol lowering.
    MacMahon S
    Postgrad Med J; 1989; 65 Suppl 1():S55-7. PubMed ID: 2695910
    [No Abstract]   [Full Text] [Related]  

  • 14. Socioeconomic differences in myocardial infarction risk among 35-64 year old women in Kaunas, Lithuania.
    Malinauskiene V; Grazuleviciene R; Azaraviciene A
    Przegl Lek; 2003; 60 Suppl 6():86-8. PubMed ID: 15106465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Assessment of the effectiveness of arterial hypertension control in an organized population by cardiovascular morbidity and mortality. I. A comparative assessment of patient groups differing in their response to a preventive program].
    Makarova TG; Britov AN; Aleksandrov AA; Loginova TI; Sapozhnikov II
    Ter Arkh; 1983; 55(1):50-3. PubMed ID: 6836526
    [No Abstract]   [Full Text] [Related]  

  • 16. The human M.O.T.: how Oxfordshire is fighting heart disease.
    Nurs Stand; 1987 Oct; 2(2):26. PubMed ID: 3328083
    [No Abstract]   [Full Text] [Related]  

  • 17. [Division of the 45- to 59-year-old male population into groups depending on the risk factors in a prophylactic study of ischemic heart disease].
    Grabauskas VI; Baubinene AV; Glazunov IS; Domarkene SB; Misiavichene IS
    Kardiologiia; 1977 Nov; 17(11):111-7. PubMed ID: 599808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of controlled trials in evaluating preventive medicine procedures.
    Rose G
    Ciba Found Symp; 1985; 110():183-202. PubMed ID: 3886329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of cardiovascular disease in a population of 180,000. 11,000 new hypertensives under treatment. Substantial reduction in the incidence of stroke cases].
    Karlsson Y
    Nord Med; 1976 Dec; 92(12):303-6. PubMed ID: 1005069
    [No Abstract]   [Full Text] [Related]  

  • 20. Myocardial infarction. Primary prevention.
    Taylor D
    Practitioner; 1990 Feb; 234(1483):168-70. PubMed ID: 2349203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.